GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Farmaceutica Remedia SA (BSE:RMAH) » Definitions » Revenue

Farmaceutica Remedia (BSE:RMAH) Revenue : lei566.8 Mil (TTM As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Farmaceutica Remedia Revenue?

Farmaceutica Remedia's revenue for the three months ended in Sep. 2023 was lei138.5 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2023 was lei566.8 Mil. Farmaceutica Remedia's Revenue per Share for the three months ended in Sep. 2023 was lei1.45. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was lei5.92.

During the past 12 months, the average Revenue per Share Growth Rate of Farmaceutica Remedia was 7.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 10.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 9.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Farmaceutica Remedia's highest 3-Year average Revenue per Share Growth Rate was 24.70% per year. The lowest was 0.10% per year. And the median was 8.60% per year.


Farmaceutica Remedia Revenue Historical Data

The historical data trend for Farmaceutica Remedia's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Farmaceutica Remedia Revenue Chart

Farmaceutica Remedia Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 464.04 446.41 441.48 477.10 535.85

Farmaceutica Remedia Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 130.78 145.68 136.26 146.35 138.46

Competitive Comparison of Farmaceutica Remedia's Revenue

For the Medical Distribution subindustry, Farmaceutica Remedia's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Farmaceutica Remedia's Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Farmaceutica Remedia's Revenue distribution charts can be found below:

* The bar in red indicates where Farmaceutica Remedia's Revenue falls into.



Farmaceutica Remedia Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was lei566.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Farmaceutica Remedia  (BSE:RMAH) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Farmaceutica Remedia Revenue Related Terms

Thank you for viewing the detailed overview of Farmaceutica Remedia's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Farmaceutica Remedia (BSE:RMAH) Business Description

Traded in Other Exchanges
N/A
Address
No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.

Farmaceutica Remedia (BSE:RMAH) Headlines

No Headlines